{"brief_title": "Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)", "brief_summary": "This study compared the safety and tolerability profile of a higher potency investigational vaccine to that of the investigational vaccine at a lower potency dose.", "condition": ["Healthy"], "intervention_type": ["Biological", "Biological"], "intervention_name": ["Comparator: Varicella Zoster Virus Vaccine", "Comparator: Varicella Zoster Virus Vaccine"], "description": ["Single 0.65 mL subcutaneous injection of higher potency zoster vaccine (~207,000 plaque-forming units [PFU]/0.65-mL dose)", "Single 0.65 mL subcutaneous injection of lower potency zoster vaccine (~58,000 plaque-forming units [PFU]/0.65-mL dose)"], "arm_group_label": ["1", "2"], "criteria": "Inclusion Criteria: - Healthy individuals 50 years of age or older with a history of chickenpox who have not had herpes zoster Exclusion Criteria : - Preexisting conditions that might affect vaccine safety such as conditions that inhibit an immune response", "gender": "All", "minimum_age": "50 Years", "maximum_age": "N/A", "healthy_volunteers": "Accepts Healthy Volunteers", "mesh_term": ["Vaccines"], "id": "NCT00092417"}